Cstone pharma stock
WebMar 27, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, … WebApr 6, 2024 · CStone Pharmaceuticals ha annunciato che la National Medical Products Administration della Cina ha accettato la domanda di licenza biologica supplementare per sugemalimab in combinazione con la... Ricerca avanzata
Cstone pharma stock
Did you know?
WebFeb 26, 2024 · Suzhou CStone Pharma raised $285 million in an Hong Kong IPO that valued the oncology company at $1.5 billion. The IPO was priced at the middle of the range, and the stock rose 7% in the first trading session. Just 2.5 years old, CStone has built a portfolio of 14 oncology drugs through novel drug discovery and in-licensings. Web17 hours ago · Petros Pharmaceuticals stock is rising alongside heavy trading this morning.; That’s despite a lack of news concerning the company. PTPI’s penny stock status may explain today’s rally.
WebOct 27, 2024 · EQRx, a startup trying to disrupt the pharmaceutical market by developing cheaper alternatives to branded drugs, has licensed two experimental cancer drugs from CStone Pharmaceuticals, a China-based company that has also attracted attention from Pfizer and a few U.S. biotechs. WebApr 11, 2024 · PLx Pharma (NASDAQ: PLXP) stock is taking a beating on Tuesday and there’s a couple of reasons investors will want to know about its fall. First off, traders will …
WebCStone is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the … WebMar 12, 2024 · SUZHOU, China, March 12, 2024 /PRNewswire/ -- CStone Pharmaceuticals (Suzhou) Co., Ltd. ("CStone", stock code: 2616.HK) announced that the National Medical Products Administration (NMPA) recently approved company's histone deacetylase 6 (HDAC6) selective inhibitor CS3003 for Phase I clinical trial in China.
WebCSTONE PHARMA-B Raises $390M by 8.8% Discounted Shrs Placement, Shr Price Falls Over 6% 2024/02/08 09:45 Recommend 4 Positive 4 Negative 5 《HKEx》- 02616 CSTONE PHARMA-B - PLACING OF NEW...
WebApr 4, 2024 · 2616 Stock Overview. About the company. CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno … te-ml 11WebStock Symbol 02616 Share Price $0.50 (As of Friday Closing) General Information Description CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular targeted drugs. einatmen konjugationWebStock Money Flow N/A PROFILE ( 2616) Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of … einat hazkani-covoWebMar 17, 2024 · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 … te-ml 12 mWebApr 12, 2024 · That’s quickly closing in on the company’s daily average trading volume of about 3.7 million shares, and markets aren’t even open yet. PLXP stock is down 31.5% … eindbod cao zuivelWebApr 10, 2024 · CStone Pharmaceuticals 02616 Stock Quote Morningstar Rating Rating as of Apr 10, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability … einck\u0027s serviceWebApr 6, 2024 · -- China's National Medical Products Administration heeft de aanvullende biologische licentieaanvraag van CStone Pharmaceuticals aanvaard voor sugemalimab als chemotherapiecombinatie bij de... 10 april 2024 eincremen konjugation